Atorvastatin Calcium Tablet
Product Images NDC 50090-7724

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-7724). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (393b5ee9 C102 40ee 9d07 B676ece72abd 01)

Image (393b5ee9 C102 40ee 9d07 B676ece72abd 01)
Chemical structure diagram of atorvastatin calcium, showing the molecular arrangement including rings, hydroxyl groups, fluorophenyl group, calcium ion complex (Ca2+), and hydration with three water molecules (3H2O).*
FDA Label Image

Image (393b5ee9 C102 40ee 9d07 B676ece72abd 02)

Image (393b5ee9 C102 40ee 9d07 B676ece72abd 02)
A line chart comparing cumulative incidence percentages over 3.5 years for atorvastatin versus placebo. The solid line represents atorvastatin with lower cumulative incidence, while the dashed line represents placebo with higher cumulative incidence. The chart includes hazard ratio and p-value details.*
FDA Label Image

Image (393b5ee9 C102 40ee 9d07 B676ece72abd 03)

Image (393b5ee9 C102 40ee 9d07 B676ece72abd 03)
A line graph depicting cumulative hazard percentage over time in years up to four years. It compares placebo (dashed line) and atorvastatin (solid line) treatments, showing a lower cumulative hazard for atorvastatin. The hazard ratio (HR) is 0.63 with a confidence interval of 0.48-0.83 and a p-value of 0.001, indicating statistical significance.*
FDA Label Image

Image (393b5ee9 C102 40ee 9d07 B676ece72abd 04)

Image (393b5ee9 C102 40ee 9d07 B676ece72abd 04)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time for atorvastatin 10 mg and 80 mg doses. The X-axis represents time in years to the first major cardiovascular endpoint, up to 5 years. The Y-axis shows the percentage of subjects experiencing the event, up to 0.2%. Two lines indicate that atorvastatin 80 mg has a lower event rate over time compared to 10 mg.*
FDA Label Image

Label Image (Lbl500907724)

Label Image (Lbl500907724)
Atorvastatin calcium 80 mg oral tablets from A-S Medication Solutions. The white label includes dosage strength, quantity (30 tablets), storage instructions (store at 68 to 77 degrees F), and packaging details. It also features NDC 50090-7724 and a QR code for package insert access.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.